2019
Delhi (India)
Seed
Zeelab Pharmacy is a rapidly expanding, disruptive force in India’s pharmaceutical retail and healthcare delivery sector. Operates across India, with a strong presence in both metro and non-metro cities. The company was launched with a mission to make high-quality, WHO-GMP certified generic medicines affordable and accessible to every Indian, addressing the country’s persistent challenge of healthcare unaffordability.
Affordable Generic Medicines: Over 2,000+ WHO-GMP certified generic medicines for a wide range of chronic and acute conditions, offered at up to 90% lower prices than branded drugs.
OTC & Health Products: Extensive range of over-the-counter medicines, vitamins, supplements and wellness products.
Cosmetics & Herbal Products: 300+ cosmetic and herbal items for personal care and wellness needs.
Surgical & Medical Supplies: Surgical products and medical devices for home and clinical use.
Online Pharmacy & Home Delivery: Fast, convenient online ordering with same-day or express home delivery across India.
Physical Pharmacy Network: 2,500+ retail outlets nationwide, providing easy access to affordable medicines.
Consultation & Support: Access to qualified pharmacists and healthcare professionals for guidance and prescription support
Direct Sales (Retail & Online): The primary revenue stream comes from direct sales of generic medicines, OTC products and health supplements through Zeelab’s own stores and website/app.
Franchise Model: Zeelab partners with franchisees to rapidly expand its retail footprint, earning revenue through franchise fees and product supply to franchise outlets.
B2B Sales: Supplies generic medicines and healthcare products to hospitals, clinics and other healthcare providers at competitive rates.
Private Label & Manufacturing: All products are manufactured in-house at WHO-GMP certified facilities, supporting high margins and quality control.
Consultation Services: Offers access to healthcare professionals and pharmacists for medical advice and prescription support via its digital platform.
Delivery Services: Monetizes convenience through express and 60-minute delivery options for online orders, especially in metro and tier-II cities.
High-Volume, Low-Margin: Focuses on driving massive sales volumes with low margins per unit, enabled by cost-efficient manufacturing and supply chain integration.
Omnichannel Reach: Combines physical stores with a strong digital presence for maximum accessibility and customer acquisition.
Brand Partnerships: Collaborates with healthcare professionals and leverages celebrity endorsements to build trust and drive adoption.
Customer Loyalty Programs: Encourages repeat purchases through discounts, offers and loyalty schemes.
B2C: End consumers seeking affordable, high-quality medicines, especially chronic care patients and families in urban and rural India.
B2B: Hospitals, clinics and healthcare providers looking for cost-effective, reliable medicine supply.
Franchise Partners: Entrepreneurs and pharmacy operators seeking to join India’s largest affordable pharmacy network.
Retail Expansion: Aggressive rollout of new stores, aiming for 100,000 outlets in five years.
Digital Innovation: Investment in fast, reliable online delivery (including 60-minute delivery) and user-friendly app/website.
Tier-II & Rural Penetration: Focused expansion into underserved cities and rural areas to democratize healthcare access.
Product Diversification: Broadening the product range to include cosmetics, herbal medicines, nutraceuticals and surgical supplies.
Brand Building: Leveraging celebrity endorsements and digital marketing to build a trusted, recognizable brand.
Operational Efficiency: Vertically integrated manufacturing and supply chain for cost control and scalability.
$2.4 million
1
$2.4Million, Seed
as of January 22, 2025
-
as of N/A
0.696
as of N/A
OTP Ventures
374
N/A
-
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
January 22, 2025 | Seed | $2.4Million | - | - | - | OTP Ventures |